31 results
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... #Metformin #CKD3 ... #CKD4 #Dosing # ... Pharmacology #VisualAbstract
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment #CKD
With the recent publication of the FDA Guidance on alcohol-based hand sanitizer compounding, I thought to
hand sanitizer compounding ... also encouraging pharmacists ... #Coronavirus #Compounding ... #Pharmacology #
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 ... Established ASCVD or CKD ... established ASCVD or CKD ... #Diabetes #DM2
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
metformin in T2D and CKD ... cardiovascular disease: CKD ... type 2 diabetes; ... , #KDIGO2020 #CKD ... in CKD #management
Diabetes – diabetic nephropathy
Majority of the literature in the area is applied to the diabetic nephropathy
Diabetes – diabetic ... applied to the diabetic ... primary cause of diabetic ... Pathophysiology #Nephrology #CKD ... #Diabetic #Nephropathy
Maximum Statin Dosing - Adjustments in CKD
Atorvastatin
Lovastatin
Pitavastatin
Pravastatin
Rosuvastatin
Simvastatin
Fluvastatin
Simvastatin/ezetimibe

doi: 10.20945/2359-3997000000306

#Statin #Dosing #CKD #pharmacology
Adjustments in CKD ... Statin #Dosing #CKD ... #pharmacology
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
and Dosing in CKD ... Prescribing #Dosing #CKD ... #pharmacology # ... algorithm #diabetes
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... patients with T2D, CKD ... and CKD should ... evidence-based pharmacologic ... #Diabetes #CKD #
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... contraindicated in CKD ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes